Advertisement

---

QRXPHARMA LIMITED

QRxPharma Updates MOXDUO® NDA Review

[2013-06-26] - New Information to Delay Planned FDA Advisory Committee Meeting and PDUFA date


QRxPharma Granted US Patent On Hybrid Opioids

[2013-06-12] - Composition of Matter Patent Provides Coverage Until 2031


FDA Sets 17 July 2013 For MOXDUO® Advisory Committee Meeting

[2013-05-17] - Committee to Review Respiratory Safety Data Comparing MOXDUO with Components


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers